AMH and obesity due to melanocortin 4 receptor deficiency: At the end of the study, 76% of patients switched from obesity to overweight, 96% of participants had normalization HOMA-IR, serum AMH levels significantly decreased, and progesterone and SHBG significantly increased after VLCKD.